Anlon Healthcare Limited has launched an Initial Public Offering (IPO) totalling ₹121.03 crore comprising a fresh issue of 1,33,00,000 equity shares.

Vidhigya Associates acted as the sole legal counsel for the offering.

The transaction team consisted of Rahul Pandey (Partner), Himanshu Pandey (Partner), Yash Desai (Senior Associate) and Darshi Shah (Associate).

Anlon Healthcare is a chemical manufacturing Company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.